22nd week of 2021 patent applcation highlights part 9 |
Patent application number | Title | Published |
20210161862 | USE OF STATINS FOR PERIODONTAL DISEASE AND BONE REGENERATION | 2021-06-03 |
20210161863 | PREPARATION AND USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS | 2021-06-03 |
20210161864 | SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE | 2021-06-03 |
20210161865 | MAZINDOL TREATMENT FOR HEROIN DEPENDENCE AND SUBSTANCE USE DISORDER | 2021-06-03 |
20210161866 | DRUG FOR USE IN COMBINATION, AND USE THEREOF FOR PREPARING DRUGS FOR TREATMENT OF HIGH-GRADE BRAIN TUMORS IN RESPONSE TO INEFFECTIVE STANDARD TREATMENT FOR POSTOPERATIVE RECURRENCE | 2021-06-03 |
20210161867 | Implantable Isoxazoline Pharmaceutical Compositions and Uses Thereof | 2021-06-03 |
20210161868 | ANTI-INFLAMMATORY THERAPY IN ARRHYTHMOGENIC CARDIOMYOPATHY (ACM) | 2021-06-03 |
20210161869 | ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS | 2021-06-03 |
20210161870 | ROFLUMILAST FORMULATIONS WITH AN IMPROVED PHARMACOKINETIC PROFILE | 2021-06-03 |
20210161871 | NON-PULSATILE PROLONGED-RELEASE BETAHISTINE ORAL SOLID COMPOSITIONS | 2021-06-03 |
20210161872 | THERAPEUTIC DRUG FOR ECTOPIC OSSIFICATION HAVING MECHANISM TO INHIBIT PAR1 | 2021-06-03 |
20210161873 | SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF | 2021-06-03 |
20210161874 | TREATMENT OF AUTOIMMUNE DISEASES WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | 2021-06-03 |
20210161875 | TOPICAL RETINOID COMPOSITIONS | 2021-06-03 |
20210161876 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALD- EHYDE | 2021-06-03 |
20210161877 | GASTROPROTECTED, HYDROPHOBIC FORMULATION OF AT LEAST ONE ACTIVE PRINCIPLE AND METHOD FOR OBTAINING SAME | 2021-06-03 |
20210161878 | (S)-3-[1-Methylpyrrolidin-2-yl]Pyridine, Analogues Thereof, Precursors Thereof, or its Derivatives, for the Use as a Pharmaceutical in Form of a Parenteral Administration and a Process for the Preparation of an Injectable Substance | 2021-06-03 |
20210161879 | FLECAINIDE COMBINATION AND CONTROLLED-RELEASE FORMULATIONS FOR TREATING HEART DISEASES | 2021-06-03 |
20210161880 | METHODS FOR TREATING DEMENTIA RELATED PSYCHOSIS | 2021-06-03 |
20210161881 | METHODS OF INHIBITING FORMATION OF ALPHA SYNUCLEIN AGGREGATES | 2021-06-03 |
20210161882 | DEPOT ADMINISTRATION OF ILOPERIDONE | 2021-06-03 |
20210161883 | EZH2 INHIBITOR-INDUCED GENE EXPRESSION | 2021-06-03 |
20210161885 | Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds | 2021-06-03 |
20210161886 | METHODS OF TREATING DEPRESSIVE DISORDERS | 2021-06-03 |
20210161887 | Novel Hydrazone Derivatives For Preventing Or Treating EBV-Related Cancers | 2021-06-03 |
20210161888 | COMPOSITION AND METHOD OF TREATING CANCER ASSOCIATED WITH EGFR MUTATION | 2021-06-03 |
20210161889 | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | 2021-06-03 |
20210161890 | COMPOSITIONS AND METHODS FOR TREATING BRAIN DYSFUNCTION | 2021-06-03 |
20210161891 | TREATMENT OF POLYCYSTIC DISEASES WITH AN HDAC6 INHIBITOR | 2021-06-03 |
20210161892 | COMPOSITION INCLUDING RILPIVIRINE AND METHOD FOR TREATING TUMORS OR CANCER | 2021-06-03 |
20210161893 | USE OF sGC STIMULATORS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH) | 2021-06-03 |
20210161894 | Compositions and Methods for Modulating Liver Endothelial Cell Fenestrations | 2021-06-03 |
20210161895 | KINASE INHIBITOR SALTS, AND COMPOSITIONS THEREOF | 2021-06-03 |
20210161896 | NOVEL SUBSTITUTED TETRAHYDROQUINOLINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | 2021-06-03 |
20210161897 | EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER | 2021-06-03 |
20210161898 | PYRIDONE A2R ANTAGONISTS | 2021-06-03 |
20210161899 | GAMMA POLYGLUTAMATED PEMETREXED AND USES THEREOF | 2021-06-03 |
20210161900 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SENESCENT TUMOR CELLS | 2021-06-03 |
20210161901 | COMPOSITIONS AND METHODS FOR INCREASING TETRAHYDROBIOPTERIN PLASMA EXPOSURE | 2021-06-03 |
20210161902 | EPICHAPEROME INHIBITOR THERAPY FOR TRAUMATIC BRAIN INJURY AND SEQUELAE THEREOF | 2021-06-03 |
20210161903 | TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG | 2021-06-03 |
20210161904 | METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF | 2021-06-03 |
20210161905 | Compositions for Preventing or Treating Dry Eye | 2021-06-03 |
20210161906 | 6-HETEROCYCLYL-4-MORPHOLIN-4-YLPYRIDINE-2-ONE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER AND DIABETES | 2021-06-03 |
20210161907 | USE OF SMALL MOLECULE FAK ACTIVATORS TO PROMOTE MUCOSAL HEALING | 2021-06-03 |
20210161908 | PREVENTATIVE AND THERAPEUTIC AGENTS FOR SARCOPENIA | 2021-06-03 |
20210161909 | COMBINATION THERAPY | 2021-06-03 |
20210161910 | Combining BACE1 Inhibitors With mGluR Agonists For Alzheimer's Disease Therapy | 2021-06-03 |
20210161911 | METHODS OF TREATING CANCER | 2021-06-03 |
20210161913 | OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER | 2021-06-03 |
20210161914 | METHODS OF TREATING ALPORT SYNDROME USING BARDOXOLONE METHYL OR ANALOGS THEREOF | 2021-06-03 |
20210161915 | GABA-A ANTAGONISTS FOR TREATING SUBSTANCE WITHDRAWAL DISORDERS | 2021-06-03 |
20210161916 | COMPOSITIONS AND METHODS FOR THE REPAIR OF MYELIN | 2021-06-03 |
20210161917 | COMPOSITION FOR SUBCUTANEOUS INJECTION, CONTAINING DEOXYCHOLIC ACID, AND PREPARATION METHOD THEREFOR | 2021-06-03 |
20210161918 | TIGECYCLINE FOR TOPICAL TREATMENT OF ROOT CANAL SPACE | 2021-06-03 |
20210161919 | Metakaryocidal Treatments | 2021-06-03 |
20210161920 | NEW FORMULATION | 2021-06-03 |
20210161921 | Silanol Based Therapeutic Payloads | 2021-06-03 |
20210161922 | ANTISENSE-INDUCED EXON EXCLUSION IN TYPE VII COLLAGEN | 2021-06-03 |
20210161923 | Prebiotic Compositions And Methods Of Production Thereof | 2021-06-03 |
20210161924 | NOVEL OLIGOSACCHARIDES FOR USE IN PREBIOTIC APPLICATIONS | 2021-06-03 |
20210161925 | METHODS AND COMPOSITIONS FOR REDUCING EPIGENETIC AGE AND MITOCHONDRIAL DYSFUNCTION | 2021-06-03 |
20210161926 | Methods for Treatment of Brain Injury and Brain Dysfunction | 2021-06-03 |
20210161927 | ISOMORPHS OF REMDESIVIR AND METHODS FOR SYNTHESIS OF SAME | 2021-06-03 |
20210161928 | CANCER THERAPY VIA A COMBINATION OF EPIGENETIC MODULATION AND IMMUNE MODULATION | 2021-06-03 |
20210161929 | USES OF VERBASCOSIDE IN TREATMENT OF DIABETIC-ASSOCIATED KDINEY INJURY AND DIABETIC-ASSOCIATED LIVER INJURY | 2021-06-03 |
20210161930 | USE OF SGLT-2 INHIBITORS IN THE DRYING-OFF OF NON-HUMAN MAMMALS | 2021-06-03 |
20210161931 | BILE ACID SYNTHESIS PROMOTER, COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS AND FOOD COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS | 2021-06-03 |
20210161932 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | 2021-06-03 |
20210161933 | KITS FOR PREVENTING AND TREATING EBOLA | 2021-06-03 |
20210161934 | ENHANCING ANTI-TUMOR RESPONSE IN MELANOMA CELLS WITH DEFECTIVE STING SIGNALING | 2021-06-03 |
20210161935 | COMBINATION THERAPY FOR TREATMENT OF HCV | 2021-06-03 |
20210161936 | METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR) | 2021-06-03 |
20210161937 | ACTIVATION OF MITOCHONDRIAL UNCOUPLING AS A THERAPEUTIC INTERVENTION | 2021-06-03 |
20210161938 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | 2021-06-03 |
20210161939 | COMPOSITION FOR TREATING A PATIENT WITH A RESPIRATORY DISEASE CAUSED BY CHRONIC INFLAMMATION, PRODUCTION METHOD, AND USE OF SAID COMPOSITION | 2021-06-03 |
20210161940 | Method and agent for lowering total cholesterol levels and for improving blood lipid spectrum composition | 2021-06-03 |
20210161941 | Formulation for the Treatment of Polymorphisms in Methyl Metabolizing Genes and Methods of Treatment Thereof | 2021-06-03 |
20210161942 | GLYCAN COMPOSITIONS AND METHODS OF USE | 2021-06-03 |
20210161943 | PAK4 INHIBITORS AND METHODS OF USE | 2021-06-03 |
20210161944 | METHODS FOR TARGETING PAIN DIRECTED AT METABOLIC PATHWAYS | 2021-06-03 |
20210161945 | HEPARIN AND HEPARAN SULPHATE OLIGOSACCHARIDES | 2021-06-03 |
20210161946 | CARRIER STATUS OF ANNEXIN A5 M2 HAPLOTYPE AND OBSTETRIC RISKS | 2021-06-03 |
20210161947 | COMPOSITIONS OF HYALURONAN WITH HIGH ELASTICITY AND USES THEREOF | 2021-06-03 |
20210161948 | POLYHYDROXYALKANOATES FOR USE IN THE PREVENTION OR TREATMENT OF AN OVERWEIGHT OR OBESITY CONDITION, OR OF METABOLIC DYSFUNCTIONS RELATED TO SAID CONDITION | 2021-06-03 |
20210161949 | PHARMACEUTICAL COMPOSITION CONTAINING DEXPANTHENOL AND POLYHEXANIDE | 2021-06-03 |
20210161950 | Veterinary Supplement for Effecting Bone and Cartilage | 2021-06-03 |
20210161951 | COMPOSITION FOR INFLAMMATORY GASTROINTESTINAL DISORDERS | 2021-06-03 |
20210161952 | Method for Preparing Metal Nanocube with Controlled Corner Sharpness Index | 2021-06-03 |
20210161953 | TRACE ELEMENTS | 2021-06-03 |
20210161954 | UNIVERSAL ANTI-CD22 CHIMERIC ANTIGEN RECEPTOR ENGINEERED IMMUNE CELLS | 2021-06-03 |
20210161955 | COMPOSITIONS CONTAINING A CELL PRODUCT COMPRISING AN EXPANDED AND ENRICHED POPULATION OF SUPERACTIVATED CYTOKINE KILLER T CELLS AND METHODS FOR MAKING SAME | 2021-06-03 |
20210161956 | T Regulatory (Treg) Cell Transplantation in Osteogenesis Imperfecta (OI) | 2021-06-03 |
20210161957 | NK CELLS AND ANTIBODIES FOR CANCER TREATMENT | 2021-06-03 |
20210161958 | COMPOSITIONS AND METHODS FOR TREATING MELANOMA WITH A CHIMERIC ANTIGEN RECEPTOR | 2021-06-03 |
20210161959 | CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY | 2021-06-03 |
20210161960 | CELL SUSPENSION FOR USE IN THE TREATMENT OF LOWER EXTREMITY PERIPHERAL ARTERY DISEASE | 2021-06-03 |
20210161961 | Modified Cell Expressing Therapeutic Agent and Uses thereof | 2021-06-03 |
20210161962 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS | 2021-06-03 |
20210161963 | METHOD FOR GENE TRANSFER INTO GAMMA-DELTA TYPE T CELL | 2021-06-03 |